SUNMAN-BIRDEM Pharma

SUNMAN-BIRDEM Pharma Ltd. is a significant player in the pharmaceutical and healthcare sectors, operating as a joint venture between the SUNMAN Group and the Diabetic Association of Bangladesh. The company is dedicated to addressing both traditional and modern healthcare challenges through innovative solutions. Its product portfolio includes essential medications such as NSAIDs and antihypertensives, underscoring its commitment to public health and patient well-being. With a strong foundation built on quality and an extensive industrial background, SUNMAN-BIRDEM Pharma serves a diverse clientele within the healthcare ecosystem, aiming to enhance accessibility and efficacy of medical treatments across its operational regions.

The company operates with a workforce of 500 - 1,000 employees, indicating a substantial operational capacity. Its revenue stands at $51.9M, reflecting its market presence and economic contribution. SUNMAN-BIRDEM Pharma is part of a larger industrial conglomerate, demonstrating versatility and a broad scope of business interests beyond pharmaceuticals. This affiliation provides a robust industrial backbone, supporting its mission to deliver high-quality healthcare products. For insights into the people driving this mission, you can Meet SUNMAN-BIRDEM Pharma's team to learn more about their leadership and expertise.

With a primary location in Bangladesh, SUNMAN-BIRDEM Pharma leverages its strategic position within Asia to serve its target markets. The company's hashtags suggest a focus on B2B and B2C engagement, alongside strengths in marketing, engineering, tech, HR, IT, and operations. This multifaceted approach allows SUNMAN-BIRDEM Pharma to adapt to evolving healthcare demands and maintain a competitive edge. Its commitment to excellence and its integrated industrial approach position it asView more...